0
No votes yet
Open Access Article

Putting Evidence Into Practice: Evidence-Based Interventions to Prevent, Manage, and Treat Chemotherapy- and Radiotherapy-Induced Diarrhea

Paula M. Muehlbauer
Deborah Thorpe
Arlene Davis
Rachael Drabot
Barbara L. Rawlings
Elizabeth Kiker
CJON 2009, 13(3), 336-341 DOI: 10.1188/09.CJON.336-341

Diarrhea is a common side effect of chemotherapy regimens, particularly fluorouracil- and irinotecan-based therapies and abdominal and pelvic radiation regimens. Diarrhea can cause depletion of fluids and electrolytes, malnutrition, dehydration, and hospitalization, all of which can lead to cardiovascular compromise and death. Therefore, diarrhea can interfere with and detract from cancer treatment by causing dosing delays or reductions. Evidence supports pharmacologic interventions such as loperamide and octreotide as recommendations for practice. Emerging evidence suggests that probiotics are likely to be effective, but more extensive research is warranted as the field evolves. Soluble fiber supplements are likely to be effective for treating chemotherapy- or radiotherapy-induced diarrhea; however, additional research is needed because the type and dose of soluble fiber most effective in treating and preventing these types of diarrhea are unknown. This article is limited to recommendations for chemotherapy- and radiotherapy-induced diarrhea. The chemotherapy regimens included in most of the studies reviewed were the commonly used regimens containing drugs such as fluorouracil, cisplatin, adriamycin, and irinotecan.

References 

American Institute of Cancer Research. (2009). Coping with the side effects of cancer treatment on your nutritional status. Retrieved September 23, 2007, from <a target="_blank" href='http://www.aicr.org/site/PageServer?pagename=dc_cr_treatment#nutrition'>...

Benson, A.B., III, Ajani, J.A., Catalano, R.B., Engelking, C., Kornblau, S.M., Martenson, J.A., Jr., et al. (2004). Recommended guidelines for the treatment of cancer treatment-induced diarrhea. <i>Journal of Clinical Oncology</i>, 22(14), 2918-2926.

Delia, P., Sansotta, G., Donato, V., Frosina, P., Messina, G., De Renzis, C., et al. (2007). Use of probiotics for prevention of radiation-induced diarrhea. <i>World Journal of Gastroenterology</i>, 13(6), 912-915.

Eastern Cooperative Oncology Group. (2007). <i>ECOG common toxicity criteria.</i> Retrieved November 15, 2007, from <a target="_blank" href='http://www.ecog.org/general/ctc.pdf'>http://www.ecog.org/general/ctc.pdf...

Food and Agriculture Organization of the United Nations and World Health Organization. (2002). <i>Guidelines for the evaluation of probiotics in food: Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food</i>. Retrieved April 23, 2009, from <a target="_blank" href='http://ftp://ftp.fao.org/es/esn/food/wgreport2.pdf'>ftp://ftp.fao.org/es...

Halmos, B. (2007). Enterotoxicity of chemotherapeutic agents. Retrieved September 10, 2007, from <a target="_blank" href='http://www.uptodate.com'>http://www.uptodate.com</a>

Janssen Pharmaceutica. (1998). <i>Loperamide</i> [Package insert]. Titusville, NJ: Author.

Kornblau, S., Benson, A.B., Catalano, R., Champlin, R.E., Engelking, C., Field, M., et al. (2000). Management of cancer treatment-related diarrhea: Issues and therapeutic strategies. <i>Journal of Pain and Symptom Management</i>, 19(2), 118-129.

Maroun, J.A., Anthony, L.B., Blais, N., Burkes, R., Dowden, S.D., Dranitsaris, G., et al. (2007). Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: A consensus statement by the Canadian Working Group on chemotherapy-induced diarrhea. <i>Current Oncology</i>, 14(1), 13-20.

Marteau, P.R., de Vrese, M., Cellier, C.J., & Schrezenmeir, J. (2001). Protection from gastrointestinal diseases with the use of probiotics. <i>American Journal of Clinical Nutrition</i>, 72(2, Suppl.), 430S-436S.

McCallum, P.D., & Polisena, C.G. (Eds.). (2000). <i>The clinical guide to oncology nutrition</i>. Chicago: American Dietetic Association.

Melnyk, B., & Fineout-Overholt, E. (2005). <i>Evidence-based practice in nursing and healthcare: A guide to best nursing practice</i>. Philadelphia: Lippincott Williams and Wilkins.

Mitchell, S.A., & Friese, C.R. (n.d.). ONS PEP (Putting Evidence Into Practice) weight of evidence classification schema: Decision rules for summative evaluation of a body of evidence. Retrieved May 7, 2009, from <a target="_blank" href='http://www.ons.org/outcomes/tables/sleep/woe.shtml'>http://www.ons.org/o...

Murphy, J., Stacey, D., Crook, J., Thompson, B., & Panetta, D. (2000). Testing control of radiation-induced diarrhea with a psyllium bulking agent: A pilot study. <i>Canadian Oncology Nursing Journal</i>, 10(3), 96-100.

National Cancer Institute. (2006). <i>Common terminology criteria for adverse events</i> [v3.0]. Retrieved November 13, 2007, from <a target="_blank" href='http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/...

O'Brien, B.E., Kaklamani, V.G., & Benson, A.B., III. (2005). The assessment and management of cancer treatment-related diarrhea. <i>Clinical Colorectal Cancer</i>, 4(6), 375-381.

Rosenoff, S. (2004). Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies. <i>Supportive Care in Cancer</i>, 12(8), 561-570

Rosenoff, S.H., Gabrail, N.Y., Conklin, R., Hohneker, J.A., Berg, W.J., Warsi, G., et al. (2006). A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy- induced diarrhea: Results of the STOP trial. <i>Journal of Supportive Oncology</i>, 4(6), 289-294.

Sabol, V.K., & Carlson, K.K. (2007). Diarrhea: Applying research to bedside practice. <i>AACN Advanced Critical Care</i>, 18(1), 32-44.

Singh, B. (2007). Psyllium as therapeutic and drug delivery agent. <i>International Journal of Pharmaceutics</i>, 334(1-2), 1-14.

Topkan, E., & Karaoglu, A. (2006). Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. <i>Oncology</i>, 71(5-6), 354-360

Urbancsek, H., Kazar, T., Mezes, I., & Neumann, K. (2001). Results of a double-blind, randomized study to evaluate the efficacy and safety of antibiophilus in patients with radiation-induced diarrhoea. <i>European Journal of Gastroenterology and Hepatology</i>, 13(4), 391-396.

U.S. Food and Drug Administration. (n.d.). <i>WHO toxicity criteria by grade</i>. Retrieved November 15, 2007, from <a target="_blank" href='http://www.fda.gov/cder/cancer/toxicityframe.htm'>http://www.fda.gov/cde...

Yavuz, M.N., Yavuz, A.A., Aydin, F., Can, G., & Kavgaci, H. (2002). The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: A randomized controlled study. <i>International Journal of Radiation Oncology, Biology, Physics</i>, 54(1), 195-202.

Zidan, J., Haim, N., Beny, A., Stein, M., Gez, E., & Kuten, A. (2001). Octreotide in the treatment of severe chemotherapy-induced diarrhea. <i>Annals of Oncology</i>, 12(2), 227-229.